I get that the trial might be delayed, so costs pushed back, but no trial at all?
Also, they could be positive about pediatric approval, which would provide funds for trials, and give confidence in paying down debt.
What exactly did BP say?
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-105
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.09 |
Change
0.000(0.00%) |
Mkt cap ! $1.244B | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 110 | $1.14 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.04 | 11645 | 1 |
View Market Depth
| Last trade - 09.56am 18/06/2024 (20 minute delay) ? |
|
|||||
|
Last
$1.10 |
Change
0.000 ( 1.08 %) |
||||
| Open | High | Low | Volume | ||
| $1.10 | $1.12 | $1.08 | 55060 | ||
| Last updated 10.14am 18/06/2024 ? | |||||
| MSB (ASX) Chart |
Day chart unavailable
